A comparison of Infliximab biosimilar (CT-P13) with referenced Infliximab in terms of efficacy,safety and quality
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2016 New trial record